Adlai Nortye

How biotech IPOs performed in the third quarter
BioPharma Dive
Tue, 10/3/23 - 10:28 am
biotech
IPOs
Adlai Nortye
RayzeBio
Neumora Therapeutics
Mira Pharmaceuticals
Turnstone Biologics
Apogee Therapeutics
Sagimet Biosciences
60 Degrees Pharma
Adlai Nortye IPO gives old Novartis cancer drug new life
BioPharma Dive
Fri, 09/29/23 - 10:22 am
Adlai Nortye
IPOs
Novartis
AN2025
head and neck cancer
solid tumors
5 Life Sciences IPOs in 2023—and the Future Forecast
BioSpace
Wed, 09/20/23 - 08:51 am
Neumora Therapeutics
RayzeBio
Adlai Nortye
Jyong Biotech
Metagenomi
Struggling Oncolytics Biotech signs $86.6M Asia deal with China’s Adlai Nortye
Endpoints
Fri, 11/17/17 - 10:21 am
Oncolytics
China
IV immuno-oncolytic virus
Adlai Nortye